$25 million gift advances Boston Medical Center’s leadership in treating and preventing addictionMarch 07, 2017
The Grayken Center for Addiction Medicine aims to be world leader in battling epidemic
Boston Medical Center, already an international leader in research, teaching, and clinical programming on substance use disorders and their consequences, announces a $25 million gift from Eilene and John Grayken to intensify BMC’s fight against the burgeoning opioid epidemic, the most pressing public health crisis of our time.
The generous gift, the largest donation in BMC’s history and the biggest private gift in the US in the last decade for addiction treatment and medicine, will create the BMC Grayken Center for Addiction Medicine. The gift was announced March 6 at a ceremony attended by CEO Kate Walsh, Mrs. Grayken, and Massachusetts Gov. Charlie Baker, among others.
“The bold goal of the BMC Grayken Center is to be the premier health institution transforming creative programs into groundbreaking clinical care innovations and prevention strategies, driving efforts to end the crisis,” said Walsh. “As a leading academic institution driving public policy on addiction disease treatment, the BMC Grayken Center team will train leaders in the field to disseminate proven approaches from these programs around the world.”
The addition of the new Grayken Center builds on BMC’s long history as one of the most comprehensive and influential treatment centers for addictions in the country, with tailored programs for the spectrum of types of patient and care setting. The Grayken Center’s mission will focus on three aspects of addiction medicine:
- Research – The Center will increase the pace of innovative research at BMC, already one of the most highly respected addictions research programs in the country, with a body of published work that has transformed addiction care. It will enable further multi-disciplinary research on new approaches examining innovative care models.
- Treatment –The Grayken Center will increase BMC’s reach in developing and testing new care models, bringing together experts to establish metrics against which outcomes can be tracked and more advanced data and analytics infrastructure developed.
- Training and Prevention –The Grayken Center will join with key government agencies and lawmakers to reduce barriers to addiction treatment. It will expand existing training programs for doctors, nurses and other clinicians on addiction medicine, and will develop educational materials for prescribers.
Michael Botticelli, former director of the White House Office of National Drug Control Policy under the Obama administration, and former director of substance abuse services for the Massachusetts Department of Public Health, said the gift from the Grayken family will allow BMC to share its innovation, research and compassionate models of addiction care more fully with the nation and even the world. “BMC is a tremendous asset in our nation’s fight against one of the great challenges of our time – the addiction and opioid overdose epidemic. I’m enormously grateful to the Grayken family for bestowing this generous gift,” he said.